Thyroid Function in Term Infants With Respiratory Distress

Sponsor
Christiana Care Health Services (Other)
Overall Status
Completed
CT.gov ID
NCT00293956
Collaborator
(none)
20
1
5.9
3.4

Study Details

Study Description

Brief Summary

This study was designed to evaluate the level of certain hormones (thyroid hormones and cortisol) in full term or close to full term infants who have respiratory distress severe enough to require respiratory support. The purpose of this study is to determine if there is a relationship between these hormone levels and how sick these infants are who require help with breathing following birth.

Hypothesis: Infants who are born full term or near full term and who have low hormone levels will have higher severity of illness.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Transient hypothyroxinemia, as demonstrated by low T4 and free T4 levels with normal levels of TSH, in preterm infants has been associated with increased severity of illness and adverse outcomes. Effects of thyroid function in term infants is less well studied. Previous research in the Special Care Nursery at Christiana Hospital has indicated that transient hypothyroxinemia in intubated term infants was associated with increased severity of illness and the need for more intensive rescue therapies. However, free T4, the biologically active substance was not measured in our previous study.

    Infants who meet criteria for the study will begin participation after parental informed consent is obtained. Infants who are enrolled will have serial measurements of thyroid stimulating hormone (TSH), T4, free T4, free T3, and cortisol. These measurements will be obtained at four specific time intervals throughout the first week of the infant's life. The medical team will be blinded to the results of the hormone testing. The results will be reviewed by an unblinded study investigator and an endocrinologist will be consulted if abnormal results are reported.

    These hormone levels will be compared with severity of illness and level of respiratory support needed in order to establish an association between thyroid function and illness severity. Illness severity will be quantified by using the Score for Neonatal Acute Physiology (SNAP). SNAP scores require collecting data from vital signs and results of labs that are considered standard of care.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    20 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Thyroid Function in Term and Near Term Infants With Respiratory Distress and Its' Relation to Severity of Illness
    Study Start Date :
    Jan 1, 2006
    Actual Primary Completion Date :
    Jul 1, 2006
    Actual Study Completion Date :
    Jul 1, 2006

    Arms and Interventions

    Arm Intervention/Treatment
    1

    Full-term and near-term infants with respiratory distress in the first 24 hours of life

    Outcome Measures

    Primary Outcome Measures

    1. To determine if thyroid function, particularly free T4, is associated with severity of illness in term and near term infants with respiratory distress who require endotracheal intubation or nasal CPAP. [Birth until 120 hours of life]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 6 Days
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Infants born > or = to 35 weeks gestation

    • Infants admitted to the neonatal intensive care unit at Christiana Hospital

    • Respiratory distress requiring use of mechanical ventilation or nasal CPAP (continuous positive airway pressure)

    • Parental informed consent

    Exclusion Criteria:
    • Infants born < 35 weeks gestation

    • Infants with documented congenital abnormalities which directly impact the cardiorespiratory system

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Christiana Hospital Newark Delaware United States 19718

    Sponsors and Collaborators

    • Christiana Care Health Services

    Investigators

    • Principal Investigator: David A. Paul, MD, Christiana Care Health Systems
    • Principal Investigator: Erika M. Yencha, MD, Christiana Care Health Systems

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00293956
    Other Study ID Numbers:
    • 25190
    First Posted:
    Feb 20, 2006
    Last Update Posted:
    Jan 18, 2008
    Last Verified:
    Jan 1, 2008

    Study Results

    No Results Posted as of Jan 18, 2008